These findings also agree with recent studies showing that PTEN loss mediates resistance to cetuximab in HNSCC, indicating the need for more treatment response PTEN predictive biomarker studies that also examines the role of HemDel events46. This evidence concerns the gene PTEN and head and neck squamous cell carcinoma.